← Eichor
Study identifier: NCT07399418 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

TRIAD - Tracking Risk in Integrated Alzheimer's Diagnostics.

Condition: Cognitive Decline  ·  Sponsor: Istituti Clinici Scientifici Maugeri SpA

PhaseN/A
Planned participants80
Who can joinAll sexes, 50 Years to no upper limit
Healthy volunteersNo

About this study

The study is based on the hypothesis that the integration of biological, psychological, and social factors, according to the biopsychosocial paradigm, allows for more accurate identification of the different stages of the Alzheimer's continuum (AD), facilitating early diagnosis and effective management. It is also hypothesized that the experience of the caregiver is a key element, capable of influencing the patient's experience and clinical course, representing a potential early indicator of risk. Primary objectives are (PO.1) Jointly analyze biological, psychological, and social factors at different stages of the AD continuum to construct multidimensional clinical profiles and integrated risk models. (PO.2) Examine the influence of psychological and social variables on the quality of life of patients and caregivers at different stages of the disease. (PO.3) Investigate the relationship between caregiver psychological well-being and patient cognitive functioning, exploring potentially bidirectional relationships. Secondary objectives are (SO.1) Compare biomarkers and neuropsychological performance at different stages of the AD clinical continuum. (SO.2) Evaluate the diagnostic effectiveness of blood and neuroimaging biomarkers in discriminating the severity of cognitive impairment. (SO.3) Explore stress and coping strategies adopted by caregivers, in relation to the stage of the disease and the quality of the dyadic relationship. (So.4) Integrate quantitative and quali…

This description comes directly from the study's public registry record.

Talk to the study team

Cira Fundarò, Neurologist  ·  +39 0385247268  ·  cira.fundaro@icsmaugeri.it

Marina Maffoni, Psychologist  ·  +39 0385247212  ·  marina.maffoni@icsmaugeri.it

Always discuss trial participation with your own doctor first.

Locations (1)

ICS Maugeri Montescano InstituteMontescano, Pavia, Italy, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07399418